Literature DB >> 1824958

Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA.

F V Alonso-Caplen1, R M Krug.   

Abstract

Influenza virus NS1 mRNA is spliced by host nuclear enzymes to form NS2 mRNA, and this splicing is regulated in infected cells such that the steady-state amount of spliced NS2 mRNA is only about 10% of that of unspliced NS1 mRNA. This regulation would be expected to result from a suppression in the rate of splicing coupled with the efficient transport of unspliced NS1 mRNA from the nucleus. To determine whether the rate of splicing of NS1 mRNA was controlled by trans factors in influenza virus-infected cells, the NS1 gene was inserted into an adenovirus vector. The rates of splicing of NS1 mRNA in cells infected with this vector and in influenza virus-infected cells were measured by pulse-labeling with [3H]uridine. The rates of splicing of NS1 mRNA in the two systems were not significantly different, strongly suggesting that the rate of splicing of NS1 mRNA in influenza virus-infected cells is controlled solely by cis-acting sequences in NS1 mRNA itself. In contrast to the rate of splicing, the extent of splicing of NS1 mRNA in the cells infected by the adenovirus recombinant was dramatically increased relative to that occurring in influenza virus-infected cells. This could be attributed largely, if not totally, to a block in the nucleocytoplasmic transport of unspliced NS1 mRNA in the recombinant-infected cells. Most of the unspliced NS1 mRNA was in the nuclear fraction, and no detectable NS1 protein was synthesized. When the 3' splice site of NS1 mRNA was inactivated by mutation, NS1 mRNA was transported and translated, indicating that the transport block occurred because NS1 rRNA was committed to the splicing pathway. This transport block is apparently obviated in influenza virus-infected cells. These experiments demonstrate the important role of the nucleocytoplasmic transport of unspliced NS1 mRNA in regulating the extent of splicing of NS1 mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824958      PMCID: PMC359785          DOI: 10.1128/mcb.11.2.1092-1098.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

2.  A block in mammalian splicing occurring after formation of large complexes containing U1, U2, U4, U5, and U6 small nuclear ribonucleoproteins.

Authors:  C H Agris; M E Nemeroff; R M Krug
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

3.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

5.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

6.  mRNA splicing efficiency in yeast and the contribution of nonconserved sequences.

Authors:  C W Pikielny; M Rosbash
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

7.  Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells.

Authors:  D Greenspan; M Krystal; S Nakada; H Arnheiter; D S Lyles; P Palese
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

8.  Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant.

Authors:  K L Berkner; P A Sharp
Journal:  Nucleic Acids Res       Date:  1985-02-11       Impact factor: 16.971

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm.

Authors:  P Legrain; M Rosbash
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

View more
  17 in total

1.  Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis.

Authors:  John C Kash; Dawn M Cunningham; Maria W Smit; Youngwoo Park; David Fritz; Jeffrey Wilusz; Michael G Katze
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes.

Authors:  M E Nemeroff; U Utans; A Krämer; R M Krug
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 3.  Diversity of coding strategies in influenza viruses.

Authors:  R A Lamb; C M Horvath
Journal:  Trends Genet       Date:  1991-08       Impact factor: 11.639

Review 4.  How does influenza virus regulate gene expression at the level of mRNA translation? Let us count the ways.

Authors:  M S Garfinkel; M G Katze
Journal:  Gene Expr       Date:  1993

5.  The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region.

Authors:  W Tan; S Schwartz
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo.

Authors:  Y Li; Z Y Chen; W Wang; C C Baker; R M Krug
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

7.  Identification of alternative splicing and negative splicing activity of a nonsegmented negative-strand RNA virus, Borna disease virus.

Authors:  K Tomonaga; T Kobayashi; B J Lee; M Watanabe; W Kamitani; K Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  Expression and characterisation of the influenza A virus non-structural protein NS1 in yeast.

Authors:  A C Ward; A A Azad; I G Macreadie
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein.

Authors:  Guifang Chen; Chien-Hung Liu; Ligang Zhou; Robert M Krug
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

Review 10.  New aspects of influenza viruses.

Authors:  M W Shaw; N H Arden; H F Maassab
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.